Literature DB >> 21585120

Risk factor analysis for early mortality and morbidity following pneumonectomy for non-small cell lung cancer.

A Stolz1, P Pafko, T Harustiak, M Smejkal, J Simonek, J Schutzner, R Lischke.   

Abstract

OBJECTIVES: The purpose of this report is to analyze factors affecting morbidity and mortality following pneumonectomy for non-small cell lung cancer (NSCLC).
METHODS: We reviewed our institutional experience with all consecutive patients undergoing pneumonectomy for NSCLC from 1998 to 2010. Patients were analyzed with regard to hospital mortality and morbidity and long-term outcome.
RESULTS: There were 310 patients following pneumonectomy. Overall 30-day mortality rate was 5.5 %. Chronic obstructive pulmonary disease, induction therapy, smoking habits and obesity had no statistical influence on short-term outcome. Coronary artery disease and respiratory failure were identified as risk factors for increased 30-day mortality (p<0.01). Right pneumonectomy and presence of respiratory failure with mechanical ventilation increases the incidence of bronchopleural fistula (p<0.01).
CONCLUSIONS: Patients with right pneumonectomies are at increased risk. Coronary artery disease and respiratory failure adversely affect morbidity and mortality after this procedure (Tab. 3, Ref. 19). Full Text in free PDF www.bmj.sk.

Entities:  

Mesh:

Year:  2011        PMID: 21585120

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  2 in total

1.  Risk factors and outcomes of bronchopleural fistula after bronchoplasty in patients with non-small cell lung cancer: a retrospective multivariate analysis.

Authors:  Zhiyu Peng; Jiandong Mei; Chengwu Liu; Chenglin Guo; Michel Gonzalez; Servet Bölükbas; Luca Voltolini; Qiang Pu; Lunxu Liu
Journal:  Transl Lung Cancer Res       Date:  2022-05

2.  Breathing exercises improve post-operative pulmonary function and quality of life in patients with lung cancer: A meta-analysis.

Authors:  Wei Liu; Ying-Li Pan; Cai-Xiang Gao; Zuo Shang; Li-Juan Ning; Xing Liu
Journal:  Exp Ther Med       Date:  2013-01-25       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.